In response to the escalating demand from clinicians and researchers for precise and fast NAD measurement, NADMED has unveiled an innovative technology designed for extracting and measuring all four NADs and two glutathiones. The method is founded on colorimetric quantification, applicable to blood, tissue, or cells.
Tecan is expanding its leading portfolio for specialist applications with the upcoming launch of Resolvex i300 and its antibody purification columns, AffinEx Protein A Capture. The products deliver new levels of efficiency and precision to proteomics workflows, including biomarker discovery, drug development and personalized medicine research.
Beckman Coulter Diagnostics unveiled its new DxC 500 AU Chemistry Analyzer, an automated clinical chemistry analyzer, at Medlab Middle East in Dubai, early February. The DxC 500 AU Chemistry Analyzer is one of several recent Beckman Coulter solutions designed to address the complete needs of healthcare systems that are looking to complement central hub laboratories […]
Proscia, a leading provider of digital and computational pathology solutions, has received US FDA 510(k) clearance for its Concentriq AP-Dx. The digital pathology solution was cleared for the purpose of primary diagnosis and should be used with the Hamamatsu NanoZoomer S360MD Slide scanner in the United States.
Revvity’s software and informatics division, Revvity Signals, has introduced the Signals Clinical solution, a software-as-a-service (SaaS), end-to-end clinical data science platform designed to centralize all clinical trial data, providing fast, actionable insights for quicker clinical decisions and accelerated market delivery of therapeutics.
Azenta has launched their BioArc Ultra (the “Ultra”), a breakthrough, automated solution for high-density, eco-friendly ultracold sample management, designed to provide a new level of performance for large-scale sample management with the potential to forever change the landscape of biorepositories.
Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced Kevin O’Reilly’s appointment as its new president succeeding Julie Sawyer Montgomery, who is now vice president and group executive at Danaher Diagnostics.
DiaSys successfully introduced Total bile acids 21 FS to determine total bile acids (TBA) in serum. Now, without altering the reagent composition and the highly sensitive enzymatic cycling method, the scope of the test has been expanded to detect TBA in human stool samples.
EUROIMMUN has introduced CE-IVDR-compliant ELISAs for detection of IgG antibodies against tick-borne encephalitis virus (TBEV) in cerebrospinal fluid (CSF) and serum samples. TBEV causes the severe and potentially fatal neurological disease TBE, which is endemic in parts of Europe and Asia and is growing in range and incidence. In TBE cases with CNS involvement, detection […]
Revvity has launched its EONIS Q system, a CE-IVD marked platform enabling laboratories in countries that accept the CE marking to adopt molecular testing for spinal muscular atrophy (SMA) and severe combined immunodeficiency (SCID) in newborns.
November 2024
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.